期刊文献+

2型糖尿病患者检测血清中IL-6和尿样中8-OHdG的变化 被引量:1

The change research of IL-6 and 8-OHdG in patients with type2 diabetes mellitus
原文传递
导出
摘要 目的探讨白介素-6(IL-6)在2型糖尿病患者糖尿病发生、发展过程中的变化。了解健康人群尿样中8-羟基脱氧鸟苷(8-OHdG)含量的正常范围,探索尿样中8-OHdG含量水平能否作为反映2型糖尿病患者DNA氧化损伤程度的直接指标。方法用(酶联免疫吸附法)ELISA分析法检测40例2型糖尿病人及40例健康检查者IL-6水平;采用ELISA检测健康人和2型糖尿病患者尿样中8-OHdG的含量。结果 2型糖尿病患者血浆中IL-6明显高于正常对照组(P<0.01)。2型糖尿病患者尿样中的8-OHdG含量为(23.58±5.42)ng/mgCr,明显高于健康人的(14.54±5.10)ng/mg Cr(P<0.01)。结论 IL-6在糖尿病的发生、发展过程中发挥作用,观察其浓度变化对探讨糖尿病的发病机制、预防及指导用药均有重要价值;同时2型糖尿病患者的DNA氧化损伤水平均高于健康人群。 [Objective]To research the changed rule of interleukin-6(IL-6) through the occurrence and development of diabetes mellitus(DM).To understand the level of urine 8-OHdG in healthy group for the evidence of correlation of level of urine 8-OHdG with the degree of oxidative DNA damage in type 2 diabetic patients.[Methods]The blood levels of IL-6 are detected by ELISA for 40 patients with 2-DM and 40 healthy adults.The level of urine 8-OHdG in healthy group and type 2 diabetic patients were measured by ELISA.[Results]The levels of IL-6 in blood plasma of patients with 2-DM are obviously higher than that in normal control group(P〈0.01).The level of urine 8-OHdG in type 2 diabetic patients were(23.58±5.42)ng/mg Cr,higher than those of healthy group(14.54±5.10 ng/mg Cr,P〈0.01).[Conclusion]IL-6 is interacted through the occurrence and development of DM,so the research is very important to study the etio pathogenesis,to prevent disease and to guide medication.The level of oxidation DNA damage in type 2 diabetic patients are higher than healthy group.
作者 朱玉玮
出处 《职业与健康》 CAS 2011年第12期1372-1373,共2页 Occupation and Health
关键词 2型糖尿病 白介素-6 8羟-基脱氧鸟苷(8-OHdG) Diabetes mellitus 2 Interleukin-6 8-hydroxy-deoxyguanine
  • 相关文献

参考文献5

二级参考文献57

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2林慰慈.生物学标志物-8-羟脱氧鸟苷的研究概况[J].卫生毒理学杂志,1994,8(4):249-253. 被引量:5
  • 3王旗,贾光,闫蕾,王昕虹.高效液相色谱-电化学检测法测定尿中8-羟基脱氧鸟苷含量[J].中华预防医学杂志,2005,39(4):280-282. 被引量:20
  • 4孙林,曾丽霞,叶任高,王斌,肖定章.白细胞介素6反义RNA对肾小球系膜细胞的影响[J].中华肾脏病杂志,1997,13(1):6-9. 被引量:8
  • 5[1] Espersen GT, Mathiesen O, Grunnet N, Jensen S et al. Cytokine plasma levels and lymphocyte subsets in patient withnewly diagnosed insulin-dependent (type 1)diabetes mellitus before and following initial insulin treatment[J]. APMIS, 1997; 101(6):703-706.
  • 6[2] Thomas MP, Hemming P, Jens M et al. Monokine antagonism is reduced in patients with IDDM[J]. Diabetes, 1994; 43(10):1242-1247.
  • 7[3] Molvig, Bak L,Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin-1, tumur necrosis factor alpha, and prostaglandin E2 shows stable interindividual difference[J]. Scand J Immunol, 1988; 27(6):705-716.
  • 8[4] Harrsion LC, Honeyman MC, De Aizpurua HJ et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subject at risk of insulin-dependent diabetes[J]. Lancet, 1993; 341(5):1365-1369.
  • 9[5] Foulis AK, McGill M,Farquharson MA. Insulitis in type 1 (insulin-γ dependent)diabetes mellitus in man: Macrophages,lymphocytes,and interferon-γ containing cells[J]. J Pathol, 1991;165(2):97-103.
  • 10[6] Kroemer G, Wick G. The role of interleukin-2 in autoimmunity [J]. Immunol Today, 1989; 10(2):245-251.

共引文献88

同被引文献6

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部